Skip to main content
CAI logo
CAI
(NASDAQ)
Caris Life Sciences, Inc.
$17.60-- (--)
Loading... - Market loading

Caris Life Sciences (CAI) Stock Price & Financial Analysis

Caris Life Sciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.82 - $17.81
52-Week High$42.50
52-Week Low$14.19
Open$17.59
Volume2.81M
Average Volume (3M)2.88M
Market Cap4.97B
Shares Outstanding282.56M
P/E Ratio (TTM)146.34
Price to Sales (P/S)5.48
Price to Book (P/B)8.38
EV/EBITDA46.16
Revenue (TTM)907.29M
Net Income (TTM)33.98M
Free Cash Flow (TTM)103.49M
EPS (TTM)$0.14
Profit Margin3.75%
Operating Margin11.94%
Return on Equity (ROE)5.73%
Debt to Equity0.73
50-Day MA$17.71
200-Day MA$23.70
52-Week Change-32.15%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateJun 9, 2021

Frequently Asked Questions About Caris Life Sciences

What is the current stock price for CAI?

As of the latest trading session, CAI stock trades at $17.60. The 52-week range is $14.19–$42.50, with a day range of $16.82–$17.80.

What is the P/E ratio for CAI?

Caris Life Sciences's trailing P/E ratio is 146.3, meaning investors pay $146.3 for every $1 of annual earnings. Caris Life Sciences operates in the Healthcare sector.

Does CAI pay dividends?

Caris Life Sciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CAI?

Based on 13 analysts, the consensus for CAI is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CAI?

Caris Life Sciences's market capitalization is $4.97B, classifying it as a mid-cap company. Caris Life Sciences operates in the Healthcare sector within the Biotechnology industry.